{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T14:37:16Z","timestamp":1759847836534},"reference-count":12,"publisher":"King Faisal Specialist Hospital and Research Centre","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Saudi Medicine"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.5144\/0256-4947.2018.420","type":"journal-article","created":{"date-parts":[[2018,12,26]],"date-time":"2018-12-26T12:54:07Z","timestamp":1545828847000},"page":"420-426","source":"Crossref","is-referenced-by-count":3,"title":["A short-term follow-up of glycemic and body weight changes in diabetic patients who replaced dipeptidyl peptidase-4 inhibitors with the sodium-glucose cotransporter 2 inhibitor empagliflozin"],"prefix":"10.5144","volume":"38","author":[{"given":"Chung-Huei","family":"Huang","sequence":"first","affiliation":[{"name":"From the Division of Endocrinology and Metabolism, Department of Internal Medicine, Chang Gung Memorial Hospital and Chang Gung University, Taoyuan City, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Yao","family":"Huang","sequence":"additional","affiliation":[{"name":"From the Division of Endocrinology and Metabolism, Department of Internal Medicine, Chang Gung Memorial Hospital and Chang Gung University, Taoyuan City, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brend Ray-Sea","family":"Hsu","sequence":"additional","affiliation":[{"name":"From the Division of Endocrinology and Metabolism, Department of Internal Medicine, Chang Gung Memorial Hospital and Chang Gung University, Taoyuan City, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3134","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1001\/jama.2018.3024","article-title":"Association between use of sodium-glucose cotransporter 2 inhibitors, glucagonlike peptide 1 agonists, and dipeptidyl peptidase 4 inhibitors with all-cause mortality in patients with type 2 diabetes","volume":"319","author":"Zheng SL","year":"2018","journal-title":"JAMA"},{"key":"e_1_3_2_3_2","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1056\/NEJMoa1515920","article-title":"Empagliflozin and progression of kidney disease in type 2 diabetes","volume":"375","author":"Wanner C","year":"2016","journal-title":"N Engl J Med"},{"key":"e_1_3_2_4_2","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman B","year":"2015","journal-title":"N Engl J Med"},{"issue":"1","key":"e_1_3_2_5_2","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.2337\/dc18-S008","article-title":"Pharmacologic approaches to glycemic treatment: standards of medical care in diabetes\u20142018","volume":"41","author":"American Diabetes Association","year":"2018","journal-title":"Diabetes Care"},{"key":"e_1_3_2_6_2","doi-asserted-by":"crossref","first-page":"384","DOI":"10.2337\/dc14-2364","article-title":"Combination of empagliflozin and linagliptin as second-line therapy in subjects with type 2 diabetes inadequately controlled on metformin","volume":"38","author":"DeFronzo RA","year":"2015","journal-title":"Diabetes Care"},{"key":"e_1_3_2_7_2","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2337\/dc14-2517","article-title":"Where does combination therapy with an SGLT2 inhibitor plus a DPP-4 inhibitor fit in the management of type 2 diabetes?","volume":"38","author":"Muhammad AG","year":"2015","journal-title":"Diabetes Care"},{"key":"e_1_3_2_8_2","doi-asserted-by":"crossref","first-page":"376","DOI":"10.2337\/dc14-1142","article-title":"Dual add-on therapy in type 2 diabetes poorly controlled with metformin monotherapy: a randomized double-blind trial of saxagliptin plus dapagliflozin addition versus single addition of saxagliptin or dapagliflozin to metformin","volume":"38","author":"Rosenstock J","year":"2015","journal-title":"Diabetes Care"},{"key":"e_1_3_2_9_2","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.2337\/db13-0604","article-title":"Novel hypothesis to explain why SGLT2 inhibitors inhibit only 30\u201350% of filtered glucose load in humans","volume":"62","author":"Abdul-Ghani MA","year":"2013","journal-title":"Diabetes"},{"key":"e_1_3_2_10_2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1463-1326.2011.01511.x","article-title":"The role of the kidneys in glucose homeostasis: a new path towards normalizing glycaemia","volume":"14","author":"DeFronzo RA","year":"2012","journal-title":"Diabetes Obes Metab"},{"key":"e_1_3_2_11_2","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1007\/s00125-012-2827-3","article-title":"Differences in the glucoselowering efficacy of dipeptidyl peptidase-4 inhibitors between Asians and non-Asians: a systematic review and meta-analysis","volume":"56","author":"Kim YG","year":"2013","journal-title":"Diabetologia"},{"key":"e_1_3_2_12_2","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.2217\/pgs.11.69","article-title":"Role of genetic variation in the human sodium\u2013glucose cotransporter 2 gene (SGLT2) in glucose homeostasis","volume":"12","author":"Enigk U","year":"2011","journal-title":"Pharmacogenomics"},{"key":"e_1_3_2_13_2","doi-asserted-by":"crossref","first-page":"5335","DOI":"10.1074\/jbc.M117.779520","article-title":"SGLT2 expression is increased in human diabetic nephropathy: SGLT2 inhibition decreases renal lipid accumulation, inflammation and the development of nephropathy in diabetic mice","volume":"292","author":"Wang XX","year":"2017","journal-title":"J Biol Chem"}],"container-title":["Annals of Saudi Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.annsaudimed.net\/index.php\/vol38\/vol38iss6\/4893.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T11:15:15Z","timestamp":1559474115000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.annsaudimed.net\/doi\/10.5144\/0256-4947.2018.420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":12,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["10.5144\/0256-4947.2018.420"],"URL":"https:\/\/doi.org\/10.5144\/0256-4947.2018.420","relation":{},"ISSN":["0256-4947","0975-4466"],"issn-type":[{"value":"0256-4947","type":"print"},{"value":"0975-4466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11]]}}}